Chemotherapy Followed by Zevalin for Relapsed Mantle Cell Lymphoma

NCT00119730 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Mantle Cell Lymphoma

Interventions

DRUG: Fludarabine
DRUG: Mitoxantrone
DRUG: Rituximab
DRUG: Zevalin

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]
[object Object]